Clinical and Biological Anti-aging Efficacy of a Cosmetic Cream

NCT ID: NCT05895591

Last Updated: 2023-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-12

Study Completion Date

2021-12-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to determine the efficacy of the investigational product "Cream " :

* on skin network after 56 days of daily application
* on biological parameters linked to cellular communication involved in senescence
* on sebum composition (metagenomics and metabolomics analysis)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be conducted as a monocentric, randomized (for side of product application on forearms), open trial.

4 visits are planned:

* Visit 1 - Inclusion (D1)
* Visit 2 - Follow-up visit (D29), a window of +72 hours is allowed for this evaluation,
* Visit 3 - End of the application period (D57), a window of +72 hours is allowed for this evaluation
* Visit 4 - Follow-up visit (D7 post-biopsies +/- 24h)

For a subject completing the study, the theoretical investigational product application will be 56 consecutive days up to 59 days maximum.

The study duration for each subject will be 67 days maximum.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anti-aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treated Group

all subjects will apply the study product

Group Type EXPERIMENTAL

Anti-aging cosmetic care product

Intervention Type OTHER

* frequency of application: Once a day (in the morning)
* modalities of application: Apply the cream on face (according to normal conditions of use) and on treated forearm, massage until complete penetration
* area: The whole face, neck, neckline and one randomized forearm (external photo-exposed area) the other forearm is untreated
* duration of investigational product application: 56 days (a window of + 72 hours is allowed)
* quantity: 2 pressures of product for the whole face, neck and neckline and 1 pressure of product for the treated forearm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anti-aging cosmetic care product

* frequency of application: Once a day (in the morning)
* modalities of application: Apply the cream on face (according to normal conditions of use) and on treated forearm, massage until complete penetration
* area: The whole face, neck, neckline and one randomized forearm (external photo-exposed area) the other forearm is untreated
* duration of investigational product application: 56 days (a window of + 72 hours is allowed)
* quantity: 2 pressures of product for the whole face, neck and neckline and 1 pressure of product for the treated forearm

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* sensitive skin (declaratory judgment)
* face skin type: combination to normal skin
* presenting wrinkles and/or finelines on the whole face
* displaying saggy skin on the face (loss of firmness)
* presenting a lack of skin radiance, dull complexion and an inhomogeneous skin on the face

Exclusion Criteria

Related to the treatment/product:

* having had any surgery, chemical or significant invasive dermo-treatment on the experimental area considered by the Investigator liable to interfere with the study data
* having undergone techniques with aesthetic aim on study areas (chemical peel, mechanical dermabrasion, laser, pulsed flash lamp etc.) or having made injections of anti-wrinkle products (collagen, hyaluronic acid, botulinic toxin etc.)
* having applied products with an anti-aging action (Retinoic acid, retinol, retinaldehyde, A.H.A. etc.)
Minimum Eligible Age

35 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pierre Fabre Dermo Cosmetique

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Spincontrol

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RV4981A20210184

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.